Kolexia
Al Jijakli Ahmad Médecine générale
Al Jijakli Ahmad
Médecine générale
Centre Hospitalier Argenteuil
Argenteuil, France
64 Activités
3 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Leucémies Tumeurs du système nerveux central Récidive tumorale locale Leucémie aiguë promyélocytaire Lymphome T Lymphome malin non hodgkinien Leucémie aigüe myéloïde Neutropénie fébrile

Collaborateurs

Voir plus
Chaoui Driss
Chaoui Driss
Centre Hospitalier Argenteuil, Argenteuil, France
Genet Philippe
Genet Philippe
Centre Hospitalier Argenteuil, Argenteuil, France
Andreoli Annalisa
Andreoli Annalisa
Hôpital Saint-Louis, Paris, France
Mesbah Louisa
Mesbah Louisa
Centre Hospitalier Argenteuil, Argenteuil, France

Industries

Voir plus
Abbvie
4 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
3 collaboration(s)
Dernière en 2023
Sanofi
2 collaboration(s)
Dernière en 2021
GSK
2 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
National Acute Promyelocytic Leukemia (APL) Observational Study NAPOLEON-Registry of the German AML Intergroup
Essai Clinique (Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH)   22 février 2024
AGORA-1 /ALFA 2100 Study : A Phase 2 Study of Gemtuzumab Ozogamicin (GO)-Gilteritinib Combination in Adults With FLT3-ITD Relapse/Refractory (R/R) AML
Essai Clinique (Centre Antoine Lacassagne)   09 novembre 2023
Mutational Profile and Dynamics of PPM1D-Mutant Clones in the Spectrum of Myeloid Disorders
65th ASH Annual Meeting Abstracts   02 novembre 2023
TRANSCRIPT: Transplantation After Complete Response In Patients With T-cell Lymphoma
Essai Clinique (Hospices Civils de Lyon)   26 septembre 2023
Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger: Long-Term Results of the Randomized Phase II PRECIS Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   14 juillet 2022
Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative study.
Haematologica   01 décembre 2021
Radiotherapy (WBRT) or Autologous Stem-Cell Transplantation (ASCT) for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Long-Term Results of the Intergroup Anocef-Goelams Randomized Phase II Precis Study
Blood   23 novembre 2021
Eltrombopag for myelodysplastic syndromes or chronic myelomonocytic leukaemia with no excess blasts and thrombocytopenia: a French multicentre retrospective real-life study.
British journal of haematology   20 juin 2021
BIG-1: Phase II/III Randomized Study to Improve Overall Survival in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus Mycophenolate Mofetil Prophylaxis of Graft Versus Host Disease in Allografted Patients in First CR : a Backbone InterGroup-1 Trial
Essai Clinique (CHU Angers)   16 octobre 2020
TEAM Conditioning (Thiotepa, Etoposide, Cytarabine, Melphalan) Prior to Autologous Hematopoietic Stem Cell Transplantation for Hodgkin and Non-Hodgkin Lymphoma: Final Results from a Prospective Multicenter Study
Blood   13 novembre 2019